175 related articles for article (PubMed ID: 17005544)
21. [Intraocular surgery for secondary retinal detachment in proliferative vitreoretinopathy].
Pournaras CJ; Donati G
Klin Monbl Augenheilkd; 1995 May; 206(5):339-42. PubMed ID: 7609381
[TBL] [Abstract][Full Text] [Related]
22. Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.
Alexander P; Prasad R; Ang A; Poulson AV; Scott JD; Snead MP
Eye (Lond); 2008 Jun; 22(6):815-8. PubMed ID: 17277751
[TBL] [Abstract][Full Text] [Related]
23. Macrophages in human epiretinal and vitreal membranes in patients with proliferative intraocular disorders.
Tang S; Gao R; Wu DZ
Yan Ke Xue Bao; 1996 Mar; 12(1):28-32. PubMed ID: 9275733
[TBL] [Abstract][Full Text] [Related]
24. [Long-term outcome after silicone oil removal].
Pavlovic S; Dick B; Schmidt KG; Tomic Z; Latinovic S
Ophthalmologe; 1995 Oct; 92(5):672-6. PubMed ID: 8750994
[TBL] [Abstract][Full Text] [Related]
25. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): design issues and implications.
Joussen AM; Kirchhof B; Schrage N; Ocklenburg C; Hilgers RD;
Acta Ophthalmol Scand; 2007 Sep; 85(6):623-30. PubMed ID: 17408389
[TBL] [Abstract][Full Text] [Related]
26. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
Heidenkummer HP; Kampik A
Ger J Ophthalmol; 1992; 1(3-4):170-5. PubMed ID: 1483131
[TBL] [Abstract][Full Text] [Related]
27. [Possibilities of silicone oil removal after complex vitreoretinal surgery].
Höing C; Kampik A; Heidenkummer HP
Fortschr Ophthalmol; 1991; 88(6):593-7. PubMed ID: 1794773
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
29. The immunological studies on proliferative intraocular disorders: investigation of activated lymphocytes, macrophages and HLA-DR.
Liu W; Wu Q; Tang S; Li Y
Yan Ke Xue Bao; 1998 Mar; 14(1):35-40. PubMed ID: 12580074
[TBL] [Abstract][Full Text] [Related]
30. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
Ahmadieh H; Feghhi M; Tabatabaei H; Shoeibi N; Ramezani A; Mohebbi MR
Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of vitreoretinal proliferation in rhegmatogenous detachment and silicone oil tamponade].
Berrod JP; Sellier A; Rozot P; Raspiller A
J Fr Ophtalmol; 1996; 19(2):97-105. PubMed ID: 8731777
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy.
Quiram PA; Gonzales CR; Hu W; Gupta A; Yoshizumi MO; Kreiger AE; Schwartz SD
Ophthalmology; 2006 Nov; 113(11):2041-7. PubMed ID: 16952397
[TBL] [Abstract][Full Text] [Related]
33. Evidence of chronic inflammation in retina excised after relaxing retinotomy for anterior proliferative vitreoretinopathy.
Limb GA; Chignell AH; Woon H; Green W; Cole CJ; Dumonde DC
Graefes Arch Clin Exp Ophthalmol; 1996 Apr; 234(4):213-20. PubMed ID: 8964525
[TBL] [Abstract][Full Text] [Related]
34. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
35. [Clinical features of silicone oil dependent eyes].
Dong FT; Dai RP; Jia Y
Zhonghua Yan Ke Za Zhi; 2008 Nov; 44(11):998-1001. PubMed ID: 19176095
[TBL] [Abstract][Full Text] [Related]
36. Retinotomy and silicone oil for detachments complicated by anterior inferior proliferative vitreoretinopathy.
Tsui I; Schubert HD
Br J Ophthalmol; 2009 Sep; 93(9):1228-33. PubMed ID: 19429589
[TBL] [Abstract][Full Text] [Related]
37. [Toxic substances with silicone oil after intraocular injections].
Bambas B; Eckardt C; Vowinkel E; Kruse H
Ophthalmologe; 1995 Oct; 92(5):663-7. PubMed ID: 8750992
[TBL] [Abstract][Full Text] [Related]
38. Primary silicone oil tamponade in the management of severe intraocular foreign body injuries: an 8-year follow-up.
Szurman P; Roters S; Grisanti S; Aisenbrey S; Rohrbach JM; Warga M; Gelisken F; Spitzer MS; Bartz-Schmidt KU
Retina; 2007 Mar; 27(3):304-11. PubMed ID: 17460585
[TBL] [Abstract][Full Text] [Related]
39. [Vitreous surgery with trypan blue staining of membranes in PVR retinal detachment surgery].
Nawrocki J; Michalewska Z; Michalewski J
Klin Monbl Augenheilkd; 2005 Jul; 222(7):572-6. PubMed ID: 16034725
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry of anterior proliferative vitreoretinopathy. Report of 11 cases.
Stödtler M; Mietz H; Wiedemann P; Heimann K
Int Ophthalmol; 1994-1995; 18(6):323-8. PubMed ID: 7642332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
